NetworkNewsBreaks Archive - Page 134 of 2115

WednesdayJul 16, 2025 12:23 pm

NetworkNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Taps IBN to Lead Corporate Communications Amid AI-Driven Oncology Pipeline Progress

Lantern Pharma (NASDAQ: LTRN), a biotech company leveraging its RADR(R) AI platform to accelerate precision oncology drug development, has engaged IBN to lead its corporate communications strategy. With clinical programs targeting lung, brain, breast, and blood cancers—including three AI-guided candidates and a CNS-focused subsidiary—Lantern is advancing multiple FDA-designated therapies in active trials. The partnership with IBN aims to expand investor awareness as Lantern pursues key milestones across its data-driven, biomarker-informed pipeline. To view the full press release, visit https://nnw.fm/sr1qx About Lantern Pharma Lantern Pharma (NASDAQ: LTRN) is an AI company transforming the cost, pace, and timeline of oncology drug discovery…

WednesdayJul 16, 2025 11:51 am

NetworkNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Raises Prices Amid Surge in Demand for Private Cybersecurity Solutions

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a Swiss-hosted cybersecurity and communications provider, has increased pricing across all service tiers in response to heightened demand driven by rising Business Email Compromise (BEC) and AI-driven attacks. Targeting high-value clients in sectors like finance, law, and government, Sekur aims to boost average revenue per user by at least 50%. New features include alias emails, SEC-compliant message archiving, and white-label capabilities. Sekur’s proprietary, non–data mining platform offers secure communication without relying on big tech infrastructure. To view the full press release, visit https://nnw.fm/GhLHg About Sekur Private Data Ltd. Sekur Private Data is…

WednesdayJul 16, 2025 11:37 am

NetworkNewsBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Reports Higher Q1 Output and Revenue Ahead of August Earnings Release

Silvercorp Metals (TSX: SVM) (NYSE American: SVM) reported preliminary results for Q1 Fiscal 2026 ended June 30, with revenue rising 13% year over year to approximately $81.3 million. Silver production rose 6% to 1.8 million ounces, with silver equivalent output up to 2.0 million ounces. Lead output climbed 1% to 15.7 million pounds, while zinc production fell 19% to 5.2 million pounds. The Ying Mining District drove performance with a 28% increase in ore processed, boosting gold output 79% to 2,050 oz. Exploration and development advanced across multiple sites, including continued drilling at Ying and GC and ramp development at…

WednesdayJul 16, 2025 11:28 am

NetworkNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, is executing a dual growth strategy focused on expanding its national network of mental health clinics through its subsidiary, HOPE Therapeutics, and advancing its proprietary NMDA-based therapies toward FDA approval. HOPE recently announced plans to deploy $10.3 million in total acquisition capital to purchase clinics that provide interventional psychiatric care focused on neuroplastic therapies like transcranial magnetic stimulation (“TMS”) and ketamine. The clinics are projected to generate $15 million in 2025 revenue, with additional acquisitions in discussion that could add another $20 million. At the same time, NRx is progressing NRX-100, a…

WednesdayJul 16, 2025 9:50 am

NetworkNewsBreaks – Fusion Fuel Green PLC (Nasdaq: HTOO) Advances Turnaround With Nasdaq Compliance, Strategic Acquisitions, and Al Shola Gas Momentum

Fusion Fuel Green (Nasdaq: HTOO) a green hydrogen and energy solutions provider, today issued a shareholder update outlining key 2025 developments. The Company completed a 1-for-35 reverse stock split effective July 14 to regain Nasdaq compliance. Following the 2024 insolvency of its Portuguese subsidiary, Fusion Fuel acquired a controlling stake in Quality Industrial Corp. and its operating unit Al Shola Al Modea Gas Distribution LLC (“Al Shola Gas”), targeting $20 million in 2025 revenue. Al Shola has booked $7.4 million in new contracts since November and added over 1,800 residential and two commercial service agreements, generating $0.9 million in recurring…

WednesdayJul 16, 2025 9:40 am

NetworkNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Initiates CUSIP Change to Bolster Shareholder Protections Amid Rebrand

SEGG Media (NASDAQ: SEGG, LTRYW), formerly Lottery.com, announced a CUSIP number change as part of its corporate rebrand and ongoing efforts to combat illicit trading activity. The move aims to enhance market transparency and counter suspected naked short selling that has impacted trading. Now trading under the SEGG ticker, the company is working with counsel at Paul Hastings LLP to pursue regulatory action while advancing its global expansion in sports, entertainment, and gaming. To view the full press release, visit https://nnw.fm/B01PH About SEGG Media Corporation SEGG Media (Nasdaq: SEGG, LTRYW) is a global sports, entertainment and gaming group operating digital…

WednesdayJul 16, 2025 9:30 am

NetworkNewsBreaks – BioAdaptives, Inc. (OTC Pink: BDPT) Prepares for National Launch of NeuroRush(TM) Nootropic in Late Summer 2025

BioAdaptives (OTC Pink: BDPT), a wellness innovator, announced the national rollout of NeuroRush(TM), its next-generation nootropic aimed at enhancing mental clarity, cognitive endurance, and stress adaptability. Following strong results in test markets, the adaptogen-based formula will launch in August/September 2025 in two versions—one with natural caffeine and one caffeine-free. Formulated with clinically studied ingredients like Rhodiola, Ashwagandha, and Bacopa, NeuroRush(TM) supports brain health without the crash of stimulants. The product will be available online and through strategic wellness partners. To view the full press release, visit https://nnw.fm/I3jid About BioAdaptives, Inc. BioAdaptives, Inc. (OTC: BDPT) is a leading innovator in the…

WednesdayJul 16, 2025 9:00 am

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Highlights August as Key Window for Commercial EV Incentives Through Bollinger Motors

Mullen Automotive (NASDAQ: MULN), through its subsidiary Bollinger Motors, announced that August will present a prime opportunity to purchase commercial EVs as New York’s Truck Voucher Incentive Program (NYTVIP) is set to be replenished. The program offers up to $144,000 in point-of-sale vouchers, which, when combined with the federal 45W tax credit of up to $40,000 for Class 4 vehicles, delivers major upfront savings. With federal credits expiring after September 30, 2025, Bollinger urges fleet operators to act swiftly. The Bollinger B4, an all-electric Class 4 chassis cab, qualifies for these programs and is engineered for performance, safety, and urban…

TuesdayJul 15, 2025 3:37 pm

NetworkNewsBreaks – ONAR Holding Corp. (ONAR) CEO Spotlights AI-Driven Strategy for the Middle Market

ONAR (OTCQB: ONAR) was recently featured on the TechMediaWire Podcast, where CEO Claude Zdanow shared his journey from musician to marketing innovator. “I started as a musician signed to a Warner Bros. imprint,” he explained. “That evolved into a music company, and eventually into advertising and marketing.” In 2007, Zdanow founded Stadiumred Studios, transforming a historic Harlem recording space into a Grammy-winning facility. He later expanded it into Stadiumred Group, a full-service marketing collective offering creative, digital, experiential, and influencer services. After exiting his last agency in 2021, Zdanow was tapped to lead ONAR Holdings. The company specializes in delivering AI-driven marketing…

TuesdayJul 15, 2025 2:30 pm

NetworkNewsBreaks – Zacks Research Releases Updated Report as Soligenix Inc. (NASDAQ: SNGX) Eyes Upcoming ‘Key Catalysts’

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a July 10 Zacks Small-Cap Research report that presented a favorable analysis, noting that the company is anticipating a number of key catalysts in the second half of 2025, including progress on its current phase 3 FLASH2 trial of HyBryte(TM) for the treatment of early-stage cutaneous T cell lymphoma (“CTCL”). According to the report, Soligenix is developing products to treat rare diseases within two business segments: Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics business segment currently has multiple products under development, and the report noted…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks